This study confirmed the up-regulation of OAS2, OAS3, and OASL in PBMCs cells and CD4+ T cells as well as up-regulation of OAS3 and OASL in CD19+ B cells in active SLE patients. This evidence concerns the gene CD19 and systemic lupus erythematosus.